Cytyc Army Contract For ThinPrep Pap Test Mobilizes Stock In September
This article was originally published in The Gray Sheet
Executive Summary
Cytyc's exclusive contract to supply the U.S. Army with ThinPrep Pap tests appeared to be the driving force behind the firm's 10.6% stock boost in September. The issue gained $2.58 to close at $26.81 for the month.